Pure Global

๐Ÿ‡จ๐Ÿ‡ญSwitzerland Medical Device Regulations

Swiss Agency for Therapeutic Products (Swissmedic)

10 Regulations
7 Categories
Filters

Showing 1-10 of 10 regulations

๐Ÿ‡จ๐Ÿ‡ญ

swissdamed

Registration

Swiss Database on Medical Devices

Swiss medical device database. Voluntary registration from August 2025; mandatory registration from July 1, 2026. Transition period until December 31, 2026.

Swissmedic (Switzerland)Effective: July 1, 2026Doc: English
๐Ÿ‡จ๐Ÿ‡ญ

IvDO Amendment 2025

IVD

Amended Ordinance on In Vitro Diagnostic Medical Devices

Incorporates EU IVD transition timelines into Swiss law. Simplified designation for non-self-testing IVDs now indefinite from January 1, 2025.

Swissmedic (Switzerland)Effective: January 1, 2025Doc: English
๐Ÿ‡จ๐Ÿ‡ญ

IvDO (SR 812.219)

IVD

Ordinance on In Vitro Diagnostic Medical Devices

Swiss ordinance for IVD medical devices aligned with EU IVDR. Establishes classification (Class A, B, C, D), performance evaluation, and transition timelines aligned with EU.

Swissmedic (Switzerland)Effective: May 26, 2022Doc: English
๐Ÿ‡จ๐Ÿ‡ญ

MedDO (SR 812.213)

Registration

Medical Devices Ordinance

Core Swiss ordinance for medical devices aligned with EU MDR. Establishes classification (Class I, IIa, IIb, III), conformity assessment, Swiss Rep requirements, and CHRN marking.

Swissmedic (Switzerland)Effective: May 26, 2021Doc: English
๐Ÿ‡จ๐Ÿ‡ญ

MedDO Article 16

Classification

Medical Device Classification Rules

Classification follows EU MDR rules. Devices categorized into Class I, IIa, IIb, III based on intended purpose and risk. Different conformity assessment procedures apply per class.

Swissmedic (Switzerland)Effective: May 26, 2021Doc: English
๐Ÿ‡จ๐Ÿ‡ญ

ClinO-MD (SR 810.306)

Clinical Trials

Ordinance on Clinical Trials with Medical Devices

Requirements for clinical trials with medical devices in Switzerland. Aligned with EU MDR clinical investigation requirements and Human Research Act.

Swissmedic (Switzerland)Effective: May 26, 2021Doc: English
๐Ÿ‡จ๐Ÿ‡ญ

MedDO Swiss Rep Requirements

Registration

Swiss Authorized Representative Requirements

Foreign manufacturers must appoint a Swiss Authorized Representative (Swiss Rep) to place medical devices on Swiss market. Swiss Rep assumes regulatory responsibilities.

Swissmedic (Switzerland)Effective: May 26, 2021Doc: English
๐Ÿ‡จ๐Ÿ‡ญ

MedDO Article 66

Vigilance

Materiovigilance and Incident Reporting

Manufacturers must report serious incidents and field safety corrective actions to Swissmedic. Post-market surveillance system required under Article 56 MedDO.

Swissmedic (Switzerland)Effective: May 26, 2021Doc: English
๐Ÿ‡จ๐Ÿ‡ญ

MedDO Article 26

GMP/QMS

Conformity Certificates and Validity

Conformity certificates valid for maximum 5 years. Extended following re-assessment. Recognized conformity assessment bodies must be designated.

Swissmedic (Switzerland)Effective: May 26, 2021Doc: English
๐Ÿ‡จ๐Ÿ‡ญ

TPA (SR 812.21)

General

Federal Act on Medicinal Products and Medical Devices (Therapeutic Products Act)

Primary Swiss law governing therapeutic products including medical devices. Establishes Swissmedic authority, market surveillance, and penalty provisions.

Swissmedic (Switzerland)Effective: January 1, 2002Doc: English
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing